Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
| Form | Size | Price | $/mg | Stock | Updated |
|---|---|---|---|---|---|
| vial | 5mg | $24.65 | $4.93/mg | In stock | Jul 5 |
| vial | 10mg | $33.15 | $3.31/mg | In stock | Jul 5 |
| vial | 5mg | $58.65 | $11.73/mg | In stock | Jul 5 |
| vial | 10mg | $84.15 | $8.41/mg | In stock | Jul 5 |
| vial | 10mg | $135.15 | $13.52/mg | In stock | Jul 5 |
Single-vial list prices — bulk or bundle orders may be lower. Verify at vendor before purchase.
The FDA PCAC advisory committee meets July 23–24, 2026 to review nominations and make recommendations on compounding eligibility — the PCAC is advisory only, and the FDA would issue any final rule on a separate, later timeline. BPC-157 is on the proposed list. If the FDA subsequently issues a final rule, a valid prescription from a licensed prescriber may be required for compounding access; timing is uncertain. Disclosed Labs does not provide medical or legal advice.
Does Crush Research sell BPC-157?
Yes — Crush Research currently lists BPC-157 in 5 variants starting at $33.15 ($3.31/mg).
Is Crush Research's BPC-157 third-party tested?
Yes — Disclosed Labs has indexed 4 Certificates of Analysis for Crush Research's BPC-157, with the most recent showing 99.7% purity. Crush Research holds an overall trust grade of A (94/100) across all 105 COAs on file.
What is Crush Research's trust grade for BPC-157?
Crush Research has an overall Disclosed Labs trust grade of A (94/100), computed from 105 COAs across all peptides. The most recent BPC-157 COA was issued by ILS Labs.
Where is the cheapest BPC-157?
As of the latest data, Alpha Peptides offers BPC-157 at $1.82/mg — compare with Crush Research's listing at $3.31/mg. See the full BPC-157 price comparison.
Is BPC-157 legal to buy?
BPC-157 is among the peptides under FDA review for the Category 1 (503A) bulk-substances list — removed from Category 2 in April 2026 but not yet on a finalized Category 1 list. The FDA PCAC committee meets July 23–24, 2026 to make recommendations on which peptides may be compounded, and under what conditions — the PCAC is advisory only, and the FDA would issue any final rule on a separate, later timeline. If a final rule is ultimately issued, a valid prescription from a licensed prescriber may be required for compounding access; timing is uncertain. Current sales are for research purposes only. Disclosed Labs does not provide medical or legal advice.
| CRBPC-10-2605-1 | Jun 2026 | 99.9% | ILS Labs | Endotoxin, Sterility, Heavy metals | Confirmed1 flag | View |
| CR-BPC10-2603-1 | Apr 2026 | 99.7% | BTLabs | Endotoxin | Unverified | View |
| CR-BPC10-0217-1 | Feb 2026 | 99.7% | Freedom Diagnostics | Endotoxin | Confirmed | View |
Disclosed Labs